Transgenic mice overexpressing TRAF2 driven by MHC promoter (MHC-TRAF2HC demonstrated the symptoms of progressive cardiac hypertrophy with increased myocardial fibrosis even after 12 weeks (Divakaran et al., 2013). This evidence concerns the gene HLA-C and cardiac hypertrophy.